Table 3. Information needs at pre- and post-trial and most important knowledge acquired.

	Most important information need		Most important information still required		Most important knowledge acquired
	Pretrial		Post-trial		Post-trial
	F	% F	F	% F	F	% F
Likelihood of a cure	19	28	10	15	3	4
Treatment side effects	10	15	4	6	1	2
Coping strategies	9	13	4	6	1	2
Diagnostic tests	8	12	0	0	1	2
Treatment duration	5	7	1	2	0	0
Aetiology	3	4	4	6	16	24
Hereditary risks	0	0	0	0	20	30
Disease advancement	0	0	0	0	3	4
Cannot decide	13	19	44	66	22	33
Totals	67	100	67	100	67	100

Note: Percentages may not equal 100 due to rounding.